Repligen
RGEN
453 hedge funds and large institutions have $7.06B invested in Repligen in 2024 Q2 according to their latest regulatory filings, with 65 funds opening new positions, 160 increasing their positions, 164 reducing their positions, and 92 closing their positions.
270% more call options, than puts
Call options by funds: $66.9M | Put options by funds: $18.1M
0.69% less ownership
Funds ownership: 100.95% → 100.26% (-0.69%)
2% less repeat investments, than reductions
Existing positions increased: 160 | Existing positions reduced: 164
7% less funds holding
Funds holding: 486 → 453 (-33)
29% less first-time investments, than exits
New positions opened: 65 | Existing positions closed: 92
32% less capital invested
Capital invested by funds: $10.3B → $7.06B (-$3.29B)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
Top Sellers
RGEN Hedge Fund Activity: Q2 2024 in Review
453 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Repligen (RGEN) for Q2 2024, worth a combined $7.06B — down 32% from $10.3B a quarter earlier.
Sellers outnumbered buyers: 92 funds closed out of RGEN and 65 opened new positions — a net loss of 27 holders — while 164 trimmed existing stakes and 160 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $163M. The largest seller was Fidelity Investments, cutting an estimated $127M.
- 453 institutional investors held Repligen (RGEN) as of Q2 2024, down from 486 in Q1 2024.
- Funds reported $7.06B of Repligen stock for Q2 2024, down 32% quarter-over-quarter.
- 65 funds opened new Repligen positions in Q2 2024 and 92 closed out, a net change of -27 holders.
- The largest Repligen buyer in Q2 2024 was T. Rowe Price Associates, an estimated $163M added.
- The largest Repligen seller in Q2 2024 was Fidelity Investments, an estimated $127M sold.
Based on aggregated 13F filings for Q2 2024.